UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: UCN-01 may stop the growth of cancer cells by blocking the enzymes necessary for
cancer cell growth. Drugs used in chemotherapy use different ways to stop cancer cells from
dividing so they stop growing or die. Combining UCN-01 with prednisone may kill more cancer
cells.
PURPOSE: Phase I trial to study the effectiveness of combining UCN-01 with prednisone in
treating patients who have refractory solid tumors or lymphoma.